CML HealthCare, a provider of medical diagnostic services, has introduced a new blood-based diagnostic test for colorectal cancer.
The new COLOGIC test is designed for screening patients who are at high risk for colorectal cancer and prevent the cause of cancer death in Canada.
Colorectal Cancer Association of Canada president Barry Stein said preventative screening and early detection can save lives of people with colorectal cancer.
"Adults should speak with their family physician about the appropriate time for them to be screened for colorectal cancer," Stein added.
CML HealthCare medical director Philip Stuart said the new blood test eliminates any excuse for delaying screening.
"In partnership with Phenomenome Discoveries Inc., the inventors of the COLOGIC test, we are pleased to offer a new screening test for colorectal cancer risk that is simple for patients and avoids multiple steps associated with fecal-based screening tests," Stuart added.
"Our message is 'speak to your family doctor and get tested'.
